Infliximab and Ulcerative Colitis

Ulcerative colitis (UC) is one of the main forms of inflammatory bowel disease. The condition causes the colon and rectum to become inflamed and ulcerated.

SciELO - Brazil - TOFACITINIB IN THE MANAGEMENT OF ULCERATIVE COLITIS REFRACTORY TO ANTI-TNF AND ANTI-INTEGRIN THERAPIES TOFACITINIB IN THE MANAGEMENT OF ULCERATIVE COLITIS REFRACTORY TO ANTI-TNF AND ANTI-INTEGRIN THERAPIES

Infliximab News, Research

Game Changer for Ulcerative Colitis Patients Failing Anti-TNF?

infliximab, gutsandgrowth

International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease

JCM, Free Full-Text

Mild-to-Moderate Ulcerative Colitis

Biologicals in treatment of acute ulcerative colitis

Bad Experience with Remicade (Infliximab) Infusion

PDF) Review Article: Acute Severe Ulcerative Colitis, An Update on Optimal Medical Management

Intestine Ulcerative Colitis Stock Vector By ©Pikovit, 46% OFF

Antidrug Antibodies to Infliximab and Adalimumab in IBD Management

Infliximab News, Research